Corticosteroid Cream on an Inflamed Facial Mole
Topical corticosteroid should not be applied to a pigmented facial “mole” or any undiagnosed suspicious lesion before evaluation. [1][2]
Topical corticosteroids can mask the appearance of skin conditions and can worsen certain infections or modify their presentation. [1][3]
Why Steroids Can Be Problematic
Topical corticosteroids can aggravate or mask skin infections, including tinea (dermatophyte infection). [1]
Tinea incognito describes dermatophyte infection with atypical appearance after topical steroid use, which can delay correct diagnosis and treatment. [3]
Steroid exposure on the face is also associated with perioral dermatitis, and discontinuation of topical steroid is part of management when steroid-associated facial dermatitis is present. [4]
Skin Cancer Concerns With “Mole” Changes
A changing mole or a mole that differs from others warrants evaluation by dermatology. [2]
A suspicious spot should be assessed urgently if it differs, is changing, itches, or bleeds. [2]
Diagnosis of suspicious pigmented or changing lesions requires skin biopsy when concern for skin cancer exists. [2]
When Evaluation Is Urgently Needed
Dermatology evaluation should be expedited when any of the following are present: [2]
- The lesion is changing or differs from other moles. [2]
- The lesion itches. [2]
- The lesion bleeds. [2]
Safer Interim Measures
Supportive care can be used while awaiting evaluation, including gentle cleansing and non-medicated moisturization to reduce dryness and irritation. [1]
Occlusive covering and further product application to the lesion should be avoided until the diagnosis is clarified, since masking and irritation can occur with topical treatments. [1]
Practical Recommendation
Topical corticosteroid cream should not be used on an inflamed dry red facial mole or any undiagnosed facial pigmented lesion until assessment is completed. [1][2]
A clinician should determine whether the lesion represents inflammation from dermatitis, infection, actinic or other skin cancer, or a benign melanocytic lesion requiring surveillance or removal. [2]
Evidence Basis and Key Clinical Risks
Topical corticosteroids can mask or worsen infections and alter lesion appearance, including dermatophyte infections (tinea incognito). [1][3]
Facial steroid-associated dermatitis (perioral dermatitis) is managed by stopping topical steroid when the condition is present. [4]
Changing or suspicious pigmented lesions require dermatology assessment because skin cancer diagnosis depends on biopsy when concern exists. [2]
If timely in-person assessment is not immediately available, teledermatology should be used for triage of a changing, itchy, or bleeding lesion. [2]